Echovirus infectious disease

Summary

Echovirus infectious disease (MONDO:0005740) is a disease. A subtype of enterovirus infectious disease — broader associated-gene and molecular evidence is on the parent page (see Disease family below).

Clinical features

No curated clinical features (Orphanet) for this disease.

Identifiers

Disease identifiers

Field	Value
Canonical name	Echovirus infectious disease
Mondo ID	MONDO:0005740
EFO	EFO:0007247
MeSH	D004457
SNOMED CT	271532008
UMLS	C0013533
MedGen	41697
Is cancer (heuristic)	no

Also known as: echo Virus infection · echo Virus infections · Echovirus caused disease or disorder · Echovirus disease or disorder · Echovirus infection · infection, echo Virus · infection, Echovirus · infections, echo Virus · infections, Echovirus

Disease family

This is a subtype of enterovirus infectious disease. Genetic, therapeutic, and trial evidence is largely curated at the broader-term level — see the parent page for the associated-gene cohort and molecular evidence.

Classification path: disease › human disease › disease by etiologic mechanism › disease of primarily extrinsic mechanism › infectious disease › viral infectious disease › primary viral infectious disease › Picornaviridae infectious disease › enterovirus infectious disease › Echovirus infectious disease

Related subtypes (5): coxsackievirus infectious disease, congenital enterovirus infection, enterovirus antenatal infection, fetal enterovirus syndrome, poliovirus infection

Genetics & variants

GWAS landscape

No GWAS associations recorded — common-variant (GWAS) studies don’t cover this disease (typical for Mendelian / rare diseases). See the curated gene cohort and Mendelian overlap below.

Variant details and genetic-evidence tiers

No tiered GWAS variants or ClinVar records for this disease.

Genes & proteins

No associated-gene cohort resolved for this disease. Atlas builds the molecular and therapeutic sections — associated genes, protein families, druggability, pathways, interactions, and drug associations — by aggregating over a disease’s associated genes (resolved via GWAS / GenCC / ClinVar / CIViC), and none resolved here. This is expected for antibody-mediated, autoimmune, or otherwise non-gene-defined conditions; the curated evidence for this disease is its clinical features, GWAS susceptibility, and clinical trials (above).

Function

No pathway enrichment — requires an associated-gene cohort.

Therapeutics

No druggable-target or therapeutic data for this disease’s cohort.

Clinical trials & evidence

Clinical trials

Clinical trials: 0.